Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival
about
Survival in glioblastoma: a review on the impact of treatment modalities.Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in GlioblastomaAn Update on the Approach to the Imaging of Brain Tumors.Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.Spatiotemporal genomic architecture informs precision oncology in glioblastoma.Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.The role of KPNβ1 in neuro-oncology.Elderly patients with newly diagnosed glioblastoma: can preoperative imaging descriptors improve the predictive power of a survival model?The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter.A continuous-infusion dynamic MRI model at 3.0 Tesla for the serial quantitative evaluation of microvascular proliferation in an animal model of glioblastoma multiforme.Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.Imaging in neuro-oncology.
P2860
Q30251810-EB37D529-A30D-476F-87EB-B48DD70BDD0EQ36097869-CE5CCD75-1444-47D6-8000-093D22B1164BQ36374577-0938A466-470F-47DE-BCB2-3957DBB66F39Q38654095-70499BF0-EE6B-4F59-A375-A8CF8931F9D7Q38678657-9A9AB7E1-A1D7-4EE6-BB20-E844EF18DA4CQ38927317-877CF3FA-195B-48E7-A171-4EC825802F32Q38975001-F60B1427-7F5C-4929-AE4E-28F7016B310CQ39028007-D7047DC0-4D0B-4DAD-AEC1-B062485C2824Q39685607-8025FDF4-85D7-4105-884A-4911B88C02C5Q42363148-8BF6674E-5218-4FF2-B695-27AC899D1769Q48182133-7DDD075E-1B12-4968-833B-D0D152359A03Q48234395-FA735B9E-3EB0-4939-96C6-DBDF51143CD0Q48361527-6F447E97-1E4F-478E-BD0C-21D88DAC07F1Q48663115-8A4F171E-E665-4775-9252-0690926ADB50Q52629217-E7668B82-3CD5-4FE2-A5F6-3AA36677D712Q54973707-0866F07A-D080-4094-962F-6DD365FE2CDB
P2860
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Multicenter imaging outcomes s ...... and progression-free survival
@ast
Multicenter imaging outcomes s ...... and progression-free survival
@en
type
label
Multicenter imaging outcomes s ...... and progression-free survival
@ast
Multicenter imaging outcomes s ...... and progression-free survival
@en
prefLabel
Multicenter imaging outcomes s ...... and progression-free survival
@ast
Multicenter imaging outcomes s ...... and progression-free survival
@en
P2093
P2860
P356
P1433
P1476
Multicenter imaging outcomes s ...... and progression-free survival
@en
P2093
Adam Flanders
Ali Shojaee Bakhtiari
Chad A Holder
Daniel L Rubin
Erich S Huang
Ginu Thomas
James Y Chen
Jixin Wang
Justin Kirby
Markus M Luedi
P2860
P304
P356
10.1093/NEUONC/NOV117
P577
2015-07-22T00:00:00Z